US Patent 9403904 Anti-DLL4 antibodies and uses thereof
Patent 9403904 was granted and assigned to Fabrus, LLC on August, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+166 characters)
Article
Patent abstract
Provided herein are anti-DLL4 antibodies and methods of using anti-DLL4 antibodies as therapeutic agents in diseases or disorders associated with DLL4.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09403904 Anti-DLL4 antibodies and uses thereof US Patent 9403904 Anti-DLL4 antibodies and uses thereof
Infobox
Patent Number
0940390400
Patent Number
940390400
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
094039040
Date of Patent
August 2, 2016
0Patent Application Number
131282360
Date Filed
November 4, 2009
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
094039040
Date of Patent
August 2, 2016
0Patent Application Number
131282360
Date Filed
November 4, 2009
0Official Website
Patent Primary Examiner
Edits on 5 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09403904 Anti-DLL4 antibodies and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09403904
Date of patent
August 2, 2016
Patent application number
13128236
Date Filed
November 4, 2009
Patent primary examiner
Find more entities like US Patent 9403904 Anti-DLL4 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
